Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | December 07, 2012 | December 07, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date December 07, 2012 · Filed December 07, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2012-12-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABBOTT LABORATORIES
Report date February 28, 2013 · Filed March 02, 2013
Section 16 reporting ended · disclosed 2013-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 137,475 |
Reported balance
After 2013-02-28 transaction · row 1
1 source rowRow 1 · 2013-02-28 · Tax withholding · Disposed 9,188 · Balance 137,475 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 4,134 |
Reported balance
Holding disclosure · report date 2013-02-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,134 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,162 | $55.33 | $396,273.46 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 19 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,677 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,033 | $55.32 | $776,305.56 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 18 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,839 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,200 | $55.31 | $619,472.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 17 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,872 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,375 | $55.30 | $297,237.50 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 16 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,072 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,500 | $55.29 | $248,805.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 15 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,447 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,700 | $55.28 | $315,096.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 14 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,947 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $55.27 | $165,810.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 13 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,647 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $55.26 | $49,734.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 12 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,647 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,933 | $55.25 | $162,048.25 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,547 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $55.20 | $5,520.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,480 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $55.17 | $11,034.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,580 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $55.16 | $154,448.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,780 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,700 | $55.15 | $148,905.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,580 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $55.14 | $22,056.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,280 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 462 | $55.13 | $25,470.06 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,680 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $55.13 | $5,512.50 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,142 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,900 | $55.12 | $711,048.00 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,242 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 638 | $55.11 | $35,160.18 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,142 Read SEC document |
| December 22, 2011 Filed Dec 23, 2011 22:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 75,203 | $53.63 | $4,032,760.88 |
DisclosureSEC source: 0001179110-11-017126 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 30, 2011 22:06 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 32,642 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001179110-11-017305 · edgar.xml · derivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 32,642 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. F1 · derivative.exercise_price: This Form 4/A is being filed to report the accurate exercise price of the reporting person's February 18, 2005 stock option grant. Read SEC document |
| December 22, 2011 Filed Dec 30, 2011 22:06 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 32,642 | $46.34 | $1,512,630.28 |
DisclosureSEC source: 0001179110-11-017305 · edgar.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This Form 4/A is being filed to report the accurate exercise price of the reporting person's February 18, 2005 stock option grant. Read SEC document |
| December 22, 2011 Filed Dec 30, 2011 22:06 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 42,561 | $53.63 | $2,282,333.63 |
DisclosureSEC source: 0001179110-11-017305 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.33 | $5,132.50 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 30 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,877 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $51.32 | $46,188.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 29 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,977 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.32 | $5,131.50 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 28 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,877 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,400 | $51.31 | $71,834.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 27 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,977 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $51.31 | $10,261.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 26 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,377 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $51.30 | $51,300.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 25 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,577 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.30 | $5,129.50 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 24 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,577 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $51.29 | $35,903.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 23 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,677 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $51.28 | $10,256.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 22 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,377 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $51.27 | $5,127.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 21 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,577 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $51.26 | $25,630.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 20 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,677 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $51.25 | $15,375.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 19 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,177 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 667 | $51.24 | $34,177.08 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 18 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,477 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $51.23 | $30,738.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 17 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,144 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $51.22 | $20,488.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 16 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,744 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 845 | $51.21 | $43,272.45 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 15 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,144 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,082 | $51.19 | $55,387.58 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 14 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,989 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $51.18 | $51,180.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 13 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,071 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $51.16 | $25,580.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 12 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,071 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $51.15 | $51,150.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,571 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $51.14 | $56,254.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,571 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $51.14 | $10,227.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,671 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $51.13 | $81,808.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,871 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $51.12 | $25,560.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,471 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $51.11 | $86,887.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,971 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $51.11 | $10,221.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,671 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 306 | $51.10 | $15,636.60 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,871 Read SEC document |
| April 26, 2011 Filed Apr 29, 2011 01:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $51.09 | $35,763.00 |
DisclosureSEC source: 0001104659-11-023803 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,177 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.